PLA Blends Patents: Top Companies & Filing Trends 2026
A data-backed look at polylactic acid (PLA) blend patents: who leads filing, how the technology splits across packaging, medical and polymer-processing classes, and where filing activity is heading through 2026.
Filing growth = 2021 (38 records) → 2024 (32); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 720 records in scope (CR5), not the ranked leaders only.
What the PLA blends patent record actually covers
Polylactic acid (PLA) blend patents span two quite different worlds under one search string: bioplastic packaging and film, where PLA is combined with other biodegradable or bio-based polymers to hit cost, barrier or compostability targets, and medical devices, where PLA blends show up in stents, implants and drug-eluting constructs. The 720 records in scope carry claims running from polymer composition and processing through to finished articles like bottles, films and delivery sheaths.
Because a single record can sit in several IPC classes at once, the composition split below adds up to more than the record total — a filing claiming a PLA/polypropylene blend for a stretch-blow-molded bottle, for instance, can carry C08L, C08J and B65D classes simultaneously.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Publication lags filing by roughly 18 months, so the last one to two years in any trend chart are undercounts, not a real drop-off.
Filing trend, 2017–2026
Annual filings rose from 14 in 2017 to a peak of 38 in 2021, then eased to 32 by 2024 (-16% over that span). 2025 and 2026 figures will continue to revise upward as later publications land.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
Technology composition by IPC subclass
C08L (polymer compositions) leads at 41.8% of the 720 records, followed by C08J (polymer processing) at 23.1% and A61F (implants and prostheses) at 18.2%. B32B laminates and B65D packaging follow close behind, showing the field splits meaningfully between materials science and applied packaging or device claims.
Shares are the percentage of the 720 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Biopolymers & Biodegradable Plastics: Polylactic Acid Blends Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about biopolymers & biodegradable plastics: polylactic acid blends patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaMost-cited records and a representative claim
Polypropylene and polylactic acid blends for injection stretch blow molding applications
Injection stretch blow molded (ISBM) articles containing bio-based polymers and methods of forming them: a propylene-based polymer is contacted with polylactic acid to form a polymeric blend, which is injection molded into a preform and then stretch-blown into a finished article such as a bottle.Filed by Fina Technology, Inc., published 2011-08-11 as US20110195210A1.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US7225518B2 | Apparatus for crimping a stent assembly | 452 |
| 2 | US6573340B1 | Biodegradable polymer films and sheets suitable for use as laminate coatings as well as wraps and other packa… | 268 |
| 3 | US20040172121A1 | Rotating balloon expandable sheath bifurcation delivery | 263 |
| 4 | US20050183259A1 | Apparatus and method for crimping a stent assembly | 234 |
| 5 | US7314480B2 | Rotating balloon expandable sheath bifurcation delivery | 231 |
| 6 | US20050154114A1 | Compatibilized blends of biodegradable polymers with improved rheology | 190 |
| 7 | US7169183B2 | Vertebral implant for promoting arthrodesis of the spine | 185 |
| 8 | US20030023306A1 | Vertebral implant for promoting arthrodesis of the spine | 182 |
| 9 | US20040106985A1 | Intravascular stent | 165 |
| 10 | US20050154442A1 | Bifurcated stent delivery system | 136 |
Citation counts favour older records simply because they have had longer to accumulate citations inside this corpus — treat them as a signal of influence, not current relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the concentration and citation patterns imply
The ranking and citation tables point to a field with one dominant filer, a long tail of single- or few-filing entrants, and an influence pattern still anchored by device-side patents from the 2000s.
One filer sets the pace, the rest is a long tail
The leading assignee holds 83 records on its own; fifth place holds 28 and tenth place 18. Combined, the top 5 account for 226 records — 31.4% of all 720 in scope — while the ranked list runs 100 assignees deep, meaning most of the field files only occasionally.
Activity has cooled from its 2021 peak, not collapsed
Filings climbed steadily from 14 in 2017 to a peak of 38 in 2021, then settled at 32 by 2024 — a -16% move over three years. That is a plateau after a growth run, not a retreat; 2025-2026 numbers are still incomplete due to publication lag.
Materials claims outweigh device claims, but not by much
C08L polymer-composition filings lead at 41.8% of the 720 records, with C08J processing close behind at 23.1%. A61F implant and prosthesis claims hold a real 18.2% share, confirming that medical-device use of PLA blends is a substantial branch rather than a niche.
Influence still traces back to early stent-delivery patents
The most-cited records in this corpus are stent-crimping and balloon-delivery device patents from the mid-2000s, not recent polymer-blend chemistry filings. That reflects how long those documents have had to accumulate citations, not that device mechanics are where current filing activity concentrates.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to biopolymers & biodegradable plastics: polylactic acid blends patent landscape, with the prior art for and against each one.
Where to take this analysis
The dataset points to specific questions worth running deeper before committing R&D or freedom-to-operate budget.
Map the medical-device sub-branch separately
A61F and A61K claims behave differently from packaging claims — different regulatory path, different citation dynamics, different competitors. Treating them as one field risks missing device-specific blocking claims.
Explore medical PLA claims in EurekaCheck the co-assignee pairs for licensing signals
The strongest co-assignee pairs in this dataset point to university-industry or inventor-company links that often precede licensing or spin-out activity worth tracking.
Trace assignee relationships in EurekaRe-run the trend once 2025-2026 publications land
Filing counts for the most recent two years are understated by publication lag alone. A follow-up pull in twelve months will show whether the 2021 peak was a high point or part of a longer plateau.
Set a tracking alert in EurekaQuestions practitioners ask about PLA blend patents
One assignee leads the ranked list with 83 records, well ahead of the rest of the field. The top five assignees combined hold 226 records, 31.4% of all 720 records in scope, and the ranking runs 100 assignees deep, so beyond the leader the field is a long tail of occasional filers rather than a handful of dominant players. Anyone doing competitive tracking should watch the leader closely but not assume the rest of the market is empty — it is fragmented, not absent.
Filing rose from 14 records in 2017 to a peak of 38 in 2021, then eased to 32 by 2024 — a -16% change over that three-year span. That reads as a plateau after a growth run rather than a collapse. Figures for 2025 and 2026 will keep revising upward as publications catch up, since publication typically lags filing by around 18 months, so it is too early to call the recent years a decline.
The record splits across two main uses: polymer composition and processing (C08L at 41.8% of 720 records, C08J at 23.1%) aimed largely at packaging and films, and medical applications, with A61F implant and prosthesis claims at 18.2% and A61K medicinal-preparation claims at 10.3%. Packaging-specific classes B32B (laminates) and B65D (containers) each sit in the mid-teens by share, confirming that packaging is a major but not sole application. A record can carry multiple classes, so these shares are not mutually exclusive.
US20110195210A1, filed by Fina Technology, covers injection stretch blow molded (ISBM) articles made by contacting a propylene-based polymer with polylactic acid to form a blend, then molding that blend into a preform and stretch-blowing it into a finished article such as a bottle. That claim scope is specific to the polypropylene-PLA combination processed by ISBM into blown articles; it does not on its own block PLA blends with other base polymers or blends processed by other methods. Anyone targeting PLA-polypropylene bottles via stretch-blow-molding should read the full claim set closely before designing a similar process.
The composition data shows heavy density in C08L polymer compositions and C08J processing, with A61F medical and B65D/B32B packaging classes all carrying real but secondary shares. Branches that combine PLA blends with additive classes (C08K, at 9.6% of records) or condensation-polymer chemistry (C08G, 9.9%) carry comparatively thinner claim density than the core composition and packaging classes, suggesting more room for a narrowly drafted first claim there. Any white-space conclusion should be checked against the specific claim language in those classes, not the class share alone.
Research Biopolymers & Biodegradable Plastics: Polylactic Acid Blends Patent Landscape in depth with Eureka
Go past this page: query the whole biopolymers & biodegradable plastics: polylactic acid blends patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.